[1] |
Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis.
Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397.
|
[2] |
Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui.
Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453.
|
[3] |
Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi.
Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459.
|
[4] |
Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde.
Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470.
|
[5] |
Hao Mingxiao, Mi Jie, Xu Zongyi.
Effectiveness of a continuity of care model in patients with tuberculous meningitis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
|
[6] |
Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei.
Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504.
|
[7] |
Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao.
Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512.
|
[8] |
Li Leilei, Shi Lei, Wang Lin, Li Hongwei, Xu Liran, Pang Yu, Song Yanzheng.
Clinical characteristics analysis of HIV-infected cases diagnosed with tuberculosis after surgery due to pulmonary nodules
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 266-273.
|
[9] |
Song Feier, Mao Yanjun, Xia Qiuyue, Zhou Yang, Lin Huan.
The prevalence and influencing factors of post-tuberculosis lung disease: A Meta-analysis
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 322-330.
|
[10] |
Zhang Mengdi, Wang Qiqi, Wang Xin, Zheng Wenjing, Sun Wenshan, Xiao Yiran, Guo Xiaomin, Liu Jianjun, Huang Fei, Yao Hongyan.
Study on pulmonary tuberculosis disease burden in the elderly aged 60 and above in China, 2005—2020
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 338-347.
|
[11] |
Liu Juxiu, Zhang Jianhua, Wen Junjun, Jiang Xiaoshuang.
Analysis and trend prediction of Mycobacterium tuberculosis drug resistance in Jilin City
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 348-354.
|
[12] |
Huang Misun, Wu Yaning, Li Guilian, Liu Haican.
Research advances of Mycobacterium tuberculosis enrichment technology
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373.
|
[13] |
Chen Wei, Li Xue, Liu Xiaoqiu, Li Yuhong, Ni Ni, Zhang Hui, Zhao Yanlin.
Interpretation and explanation about the National Tuberculosis Prevention and Control Plan (2024—2030)
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 130-136.
|
[14] |
Li Qi, Wang Yujin, Wang Xueyu, Chu Naihui, Nie Wenjuan.
Study on the metabolic interaction mechanism between the novel compound WX-081 and clarithromycin
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 142-149.
|
[15] |
Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao.
Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163.
|